The community oncology services market size is expected to see strong growth in the next few years. It will grow to $79.95 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing adoption of precision oncology therapies, rising demand for localized cancer care, expansion of tele-oncology services, growing integration of genomic diagnostics, increasing focus on value-based cancer care. Major trends in the forecast period include expansion of community-based cancer care models, growing adoption of personalized oncology treatment plans, increased integration of digital patient management systems, rising use of outpatient oncology services, enhanced focus on supportive and palliative care.
The rising prevalence of cancer is expected to drive the growth of the community oncology services market in the coming years. Cancer prevalence refers to the total number of individuals living with cancer or who have previously been diagnosed and remain alive within a specific population at a given time. The increasing prevalence of cancer is largely attributed to an aging population, as advancing age represents the most significant risk factor for cancer development, with most cancer diagnoses occurring among individuals aged 65 and older as life expectancy continues to rise. The growing cancer burden directly increases the demand for outpatient cancer care facilities that deliver services such as chemotherapy, radiation therapy, diagnostic testing, and supportive care within community-based settings located closer to patients’ homes. For example, in February 2024, according to the World Health Organization, a Switzerland-based international organization focused on global health policy and public health initiatives, more than 35 million new cancer cases are projected by 2050, representing a 77% increase compared to the estimated 20 million cases recorded in 2022. Therefore, the increasing prevalence of cancer is contributing to the expansion of the community oncology services market.
Major companies operating in the community oncology services market are increasing their investments in cancer therapies and oncology-related initiatives to support efforts in combating cancer. Investments in oncology services serve as a critical link between the delivery of high-quality cancer care and the development of sustainable healthcare systems. For instance, in March 2023, Pfizer, a US-based pharmaceutical company, merged with Seagen, a US-based biotechnology company, through a $43 billion investment aimed at strengthening cancer treatment capabilities. This transaction expanded Pfizer’s presence in the oncology sector and reinforced its commitment to addressing cancer, one of the leading causes of death globally.
In September 2023, American Oncology Network LLC, a US-based network of community oncology practices, partnered with Digital Transformation Opportunities Corp. Through this collaboration, the organizations aim to add new providers to the AON network, scale ancillary services, and expand existing offerings to better serve the broader oncology market. Digital Transformation Opportunities Corp. is a US-based company focused on advancing solutions within the healthcare industry.
Major companies operating in the community oncology services market are US Oncology Network, OneOncology, Florida Cancer Specialists & Research Institute (FCS), The Oncology Institute, Community Care Physicians, P.C. (CCP), GenesisCare, Getwell Oncology, Icon Oncology, Nebraska Cancer Specialists, Doctors Medical Center, Oncology Specialists SC, Baptist Cancer Center, Mayo Clinic, Cleveland Clinic, Fred Hutchinson Cancer Research Center, Tufts Medical Center, Abramson Cancer Center, The University of Texas Southwestern Medical Center, King Hussein Cancer Center (KHCC), Princess Noorah Oncology Center (PNOC), King Faisal Specialist Hospital and Research Centre.
North America was the largest region in the community oncology services market in 2025. Western Europe was the second largest region in the global oncology services market. The regions covered in the community oncology services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the community oncology services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the community oncology services market by increasing costs of imported oncology drugs, infusion equipment, diagnostic imaging systems, and radiation therapy components. Community clinics in North America and Europe are most affected due to reliance on imported pharmaceuticals and medical technologies, while Asia-Pacific faces rising costs for advanced cancer treatment equipment. These tariffs are contributing to higher operational expenses for oncology practices. However, they are also supporting domestic drug manufacturing, localized equipment sourcing, and regional oncology infrastructure development.
The community oncology services market research report is one of a series of new reports that provides community oncology services market statistics, including community oncology services industry global market size, regional shares, competitors with a community oncology services market share, detailed community oncology services market segments, market trends and opportunities, and any further data you may need to thrive in the community oncology services industry. This community oncology services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Community oncology services refer to specialized cancer care delivered in local settings for the prevention, diagnosis, treatment, and ongoing management of cancer, typically through community-based oncology practices and clinics. The primary objective of these services is to provide accessible, comprehensive, and patient-centered cancer care, including coordinated treatment plans and supportive services. By offering care within the community, these services aim to enhance patient outcomes and quality of life while reducing the need for extensive travel for patients and their families.
The main types of community oncology services include small, medium, and large community oncology clinics. A small community oncology clinic typically consists of a single oncologist operating from one office, supported by a team that may include physician extenders, nurses, pharmacists, pharmacy technicians, and other staff members. Community oncology services address a wide range of cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, ovarian cancer, prostate cancer, skin cancer, pancreatic cancer, blood cancer, colorectal cancer, and others. Treatment approaches encompass various modalities such as medical oncology, radiation oncology, surgical oncology, and others.
The community oncology services market includes revenues earned by entities by providing diagnostic, corrective and preventive treatment services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
Executive Summary
Community Oncology Services Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses community oncology services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for community oncology services? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The community oncology services market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Small Community Oncology Clinics; Medium Community Oncology Clinics; Large Community Oncology Clinics2) By Cancer Type: Breast Cancer; Lung Cancer; Kidney Cancer; Ovarian Cancer; Prostate Cancer; Skin Cancer; Pancreatic Cancer; Blood Cancer; Colorectal Cancer; Other Cancer Types
3) By Therapy Type: Medical Oncology; Radiation Oncology; Surgical Oncology; Other Therapy Types
Subsegments:
1) By Small Community Oncology Clinics: Independent Oncology Practices; Single-Physician Oncology Offices; Community-Based Cancer Screening And Prevention Services2) By Medium Community Oncology Clinics: Multi-Physician Oncology Practices; Integrated Community Cancer Centers; Outpatient Treatment Facilities; Community-Based Clinical Trials
3) By Large Community Oncology Clinics: Comprehensive Cancer Centers; Academic-Affiliated Community Oncology Practices; Multi-Disciplinary Treatment Centers; Specialized Oncology Services
Companies Mentioned: US Oncology Network; OneOncology; Florida Cancer Specialists & Research Institute (FCS); The Oncology Institute; Community Care Physicians, P.C. (CCP); GenesisCare; Getwell Oncology; Icon Oncology; Nebraska Cancer Specialists; Doctors Medical Center; Oncology Specialists SC; Baptist Cancer Center; Mayo Clinic; Cleveland Clinic; Fred Hutchinson Cancer Research Center; Tufts Medical Center; Abramson Cancer Center; The University of Texas Southwestern Medical Center; King Hussein Cancer Center (KHCC); Princess Noorah Oncology Center (PNOC); King Faisal Specialist Hospital and Research Centre
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Community Oncology Services market report include:- US Oncology Network
- OneOncology
- Florida Cancer Specialists & Research Institute (FCS)
- The Oncology Institute
- Community Care Physicians, P.C. (CCP)
- GenesisCare
- Getwell Oncology
- Icon Oncology
- Nebraska Cancer Specialists
- Doctors Medical Center
- Oncology Specialists SC
- Baptist Cancer Center
- Mayo Clinic
- Cleveland Clinic
- Fred Hutchinson Cancer Research Center
- Tufts Medical Center
- Abramson Cancer Center
- The University of Texas Southwestern Medical Center
- King Hussein Cancer Center (KHCC)
- Princess Noorah Oncology Center (PNOC)
- King Faisal Specialist Hospital and Research Centre
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 58.99 Billion |
| Forecasted Market Value ( USD | $ 79.95 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |


